JP5337912B2 - シース流装置及び方法 - Google Patents
シース流装置及び方法 Download PDFInfo
- Publication number
- JP5337912B2 JP5337912B2 JP2012515162A JP2012515162A JP5337912B2 JP 5337912 B2 JP5337912 B2 JP 5337912B2 JP 2012515162 A JP2012515162 A JP 2012515162A JP 2012515162 A JP2012515162 A JP 2012515162A JP 5337912 B2 JP5337912 B2 JP 5337912B2
- Authority
- JP
- Japan
- Prior art keywords
- sample
- flow
- sheath
- fluid
- sheath flow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 185
- 239000012530 fluid Substances 0.000 claims abstract description 277
- 238000000926 separation method Methods 0.000 claims abstract description 75
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 59
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 56
- 238000012544 monitoring process Methods 0.000 claims abstract description 32
- 238000012545 processing Methods 0.000 claims abstract description 30
- 230000009871 nonspecific binding Effects 0.000 claims abstract description 28
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 28
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 28
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 28
- 210000004027 cell Anatomy 0.000 claims description 193
- 230000005291 magnetic effect Effects 0.000 claims description 112
- 239000006249 magnetic particle Substances 0.000 claims description 103
- 241000894007 species Species 0.000 claims description 101
- 239000000872 buffer Substances 0.000 claims description 71
- 210000004881 tumor cell Anatomy 0.000 claims description 71
- 210000000130 stem cell Anatomy 0.000 claims description 57
- 238000011282 treatment Methods 0.000 claims description 55
- 239000002245 particle Substances 0.000 claims description 54
- 210000004369 blood Anatomy 0.000 claims description 46
- 239000008280 blood Substances 0.000 claims description 46
- 239000003153 chemical reaction reagent Substances 0.000 claims description 40
- 108091023037 Aptamer Proteins 0.000 claims description 39
- 238000012512 characterization method Methods 0.000 claims description 30
- 238000011144 upstream manufacturing Methods 0.000 claims description 30
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 claims description 27
- 238000002372 labelling Methods 0.000 claims description 24
- 239000011324 bead Substances 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 20
- 230000015572 biosynthetic process Effects 0.000 claims description 18
- 239000007853 buffer solution Substances 0.000 claims description 18
- 238000012216 screening Methods 0.000 claims description 18
- 238000011221 initial treatment Methods 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 241000700605 Viruses Species 0.000 claims description 13
- 230000003287 optical effect Effects 0.000 claims description 13
- 238000011156 evaluation Methods 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 238000004113 cell culture Methods 0.000 claims description 9
- 229940124597 therapeutic agent Drugs 0.000 claims description 9
- 238000009104 chemotherapy regimen Methods 0.000 claims description 8
- 238000003860 storage Methods 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 238000001574 biopsy Methods 0.000 claims description 5
- 230000002062 proliferating effect Effects 0.000 claims description 5
- 201000005787 hematologic cancer Diseases 0.000 claims description 4
- 238000001356 surgical procedure Methods 0.000 claims description 4
- 238000002560 therapeutic procedure Methods 0.000 claims description 4
- 206010064571 Gene mutation Diseases 0.000 claims description 3
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 241001515965 unidentified phage Species 0.000 claims description 3
- 230000033001 locomotion Effects 0.000 claims description 2
- 238000011269 treatment regimen Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 28
- 238000002955 isolation Methods 0.000 abstract description 15
- 239000013060 biological fluid Substances 0.000 abstract 1
- 238000011285 therapeutic regimen Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 298
- 239000010410 layer Substances 0.000 description 54
- 239000000126 substance Substances 0.000 description 32
- 239000007787 solid Substances 0.000 description 27
- 238000009739 binding Methods 0.000 description 26
- 230000027455 binding Effects 0.000 description 25
- 239000000047 product Substances 0.000 description 24
- 206010028980 Neoplasm Diseases 0.000 description 23
- 230000005294 ferromagnetic effect Effects 0.000 description 23
- 230000006870 function Effects 0.000 description 23
- 238000004519 manufacturing process Methods 0.000 description 23
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical group [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 22
- 238000004458 analytical method Methods 0.000 description 21
- 238000010584 magnetic trap Methods 0.000 description 21
- 239000000463 material Substances 0.000 description 20
- 238000011065 in-situ storage Methods 0.000 description 16
- 238000003199 nucleic acid amplification method Methods 0.000 description 16
- 230000003321 amplification Effects 0.000 description 14
- 201000011510 cancer Diseases 0.000 description 14
- 238000003752 polymerase chain reaction Methods 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 13
- 210000001124 body fluid Anatomy 0.000 description 12
- 239000000090 biomarker Substances 0.000 description 11
- 239000010839 body fluid Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 230000007246 mechanism Effects 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 238000002156 mixing Methods 0.000 description 10
- 229910052759 nickel Inorganic materials 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- 230000004888 barrier function Effects 0.000 description 9
- 230000007613 environmental effect Effects 0.000 description 9
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 9
- 239000003570 air Substances 0.000 description 8
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 8
- 238000005755 formation reaction Methods 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 239000012472 biological sample Substances 0.000 description 7
- 230000009089 cytolysis Effects 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 238000007726 management method Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229960000074 biopharmaceutical Drugs 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000005266 circulating tumour cell Anatomy 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000004700 fetal blood Anatomy 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 5
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 5
- 238000009098 adjuvant therapy Methods 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 238000001212 derivatisation Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 230000002934 lysing effect Effects 0.000 description 5
- 238000000838 magnetophoresis Methods 0.000 description 5
- 238000002493 microarray Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000013615 primer Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000012902 Nervous system disease Diseases 0.000 description 4
- 208000025966 Neurological disease Diseases 0.000 description 4
- 239000012807 PCR reagent Substances 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 229960003920 cocaine Drugs 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000007885 magnetic separation Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000013618 particulate matter Substances 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 238000002823 phage display Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000006978 adaptation Effects 0.000 description 3
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 230000006037 cell lysis Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000003302 ferromagnetic material Substances 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002826 magnetic-activated cell sorting Methods 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 210000005087 mononuclear cell Anatomy 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 210000003463 organelle Anatomy 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000011241 protective layer Substances 0.000 description 3
- 238000001742 protein purification Methods 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 238000012286 ELISA Assay Methods 0.000 description 2
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108091005461 Nucleic proteins Proteins 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 108010067390 Viral Proteins Proteins 0.000 description 2
- 210000004504 adult stem cell Anatomy 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000002487 chromatin immunoprecipitation Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000001952 enzyme assay Methods 0.000 description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 2
- 238000011066 ex-situ storage Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000011331 genomic analysis Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000002032 lab-on-a-chip Methods 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000006148 magnetic separator Substances 0.000 description 2
- 210000004779 membrane envelope Anatomy 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000012521 purified sample Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000001525 receptor binding assay Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013077 target material Substances 0.000 description 2
- 238000005382 thermal cycling Methods 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 206010050337 Cerumen impaction Diseases 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 208000023178 Musculoskeletal disease Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 101800004937 Protein C Proteins 0.000 description 1
- 241000711798 Rabies lyssavirus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101800001700 Saposin-D Proteins 0.000 description 1
- 102400000827 Saposin-D Human genes 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 210000003663 amniotic stem cell Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 238000005102 attenuated total reflection Methods 0.000 description 1
- 230000008275 binding mechanism Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000002533 bulbourethral gland Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229930003827 cannabinoid Natural products 0.000 description 1
- 239000003557 cannabinoid Substances 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 210000002939 cerumen Anatomy 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000003891 environmental analysis Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000003920 environmental process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000011058 failure modes and effects analysis Methods 0.000 description 1
- 210000000604 fetal stem cell Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000010370 hearing loss Effects 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000013210 hematogenous Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 201000010901 lateral sclerosis Diseases 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 229960001252 methamphetamine Drugs 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000001393 microlithography Methods 0.000 description 1
- 238000005459 micromachining Methods 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 208000005264 motor neuron disease Diseases 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000005088 multinucleated cell Anatomy 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002091 nanocage Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000006320 pegylation Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 238000002818 protein evolution Methods 0.000 description 1
- 238000000164 protein isolation Methods 0.000 description 1
- 210000004915 pus Anatomy 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 238000011519 second-line treatment Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000009168 stem cell therapy Methods 0.000 description 1
- 238000002660 stem cell treatment Methods 0.000 description 1
- 238000009580 stem-cell therapy Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- -1 temperature Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000000107 tumor biomarker Substances 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
- B01L3/502776—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for focusing or laminating flows
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/005—Pretreatment specially adapted for magnetic separation
- B03C1/01—Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/025—High gradient magnetic separators
- B03C1/031—Component parts; Auxiliary operations
- B03C1/033—Component parts; Auxiliary operations characterised by the magnetic circuit
- B03C1/0332—Component parts; Auxiliary operations characterised by the magnetic circuit using permanent magnets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/28—Magnetic plugs and dipsticks
- B03C1/288—Magnetic plugs and dipsticks disposed at the outer circumference of a recipient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
- B01L2200/0652—Sorting or classification of particles or molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/043—Moving fluids with specific forces or mechanical means specific forces magnetic forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/08—Regulating or influencing the flow resistance
- B01L2400/084—Passive control of flow resistance
- B01L2400/086—Passive control of flow resistance using baffles or other fixed flow obstructions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/18—Magnetic separation whereby the particles are suspended in a liquid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/22—Details of magnetic or electrostatic separation characterised by the magnetic field, e.g. its shape or generation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/26—Details of magnetic or electrostatic separation for use in medical or biological applications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/0098—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
- G01N35/1095—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices for supplying the samples to flow-through analysers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Fluid Mechanics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18591909P | 2009-06-10 | 2009-06-10 | |
| US61/185,919 | 2009-06-10 | ||
| US31362510P | 2010-03-12 | 2010-03-12 | |
| US61/313,625 | 2010-03-12 | ||
| US12/813,285 US8263387B2 (en) | 2009-06-10 | 2010-06-10 | Sheath flow devices and methods |
| PCT/US2010/038229 WO2010144745A2 (en) | 2009-06-10 | 2010-06-10 | Sheath flow devices and methods |
| US12/813,285 | 2010-06-10 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012530246A JP2012530246A (ja) | 2012-11-29 |
| JP2012530246A5 JP2012530246A5 (enExample) | 2013-07-25 |
| JP5337912B2 true JP5337912B2 (ja) | 2013-11-06 |
Family
ID=43309472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012515162A Expired - Fee Related JP5337912B2 (ja) | 2009-06-10 | 2010-06-10 | シース流装置及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8263387B2 (enExample) |
| EP (1) | EP2440941B1 (enExample) |
| JP (1) | JP5337912B2 (enExample) |
| CN (1) | CN102713640B (enExample) |
| DK (1) | DK2440941T3 (enExample) |
| PL (1) | PL2440941T3 (enExample) |
| PT (1) | PT2440941T (enExample) |
| SM (1) | SMT201700421T1 (enExample) |
| WO (1) | WO2010144745A2 (enExample) |
Families Citing this family (114)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11243494B2 (en) | 2002-07-31 | 2022-02-08 | Abs Global, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
| SG149889A1 (en) | 2003-10-30 | 2009-02-27 | Cytonome Inc | Multilayer hydrodynamic sheath flow structure |
| US10908066B2 (en) | 2010-11-16 | 2021-02-02 | 1087 Systems, Inc. | Use of vibrational spectroscopy for microfluidic liquid measurement |
| JP5651485B2 (ja) * | 2011-01-14 | 2015-01-14 | 株式会社日立ハイテクノロジーズ | 核酸分析装置 |
| WO2012106748A1 (en) * | 2011-02-07 | 2012-08-16 | Empire Technology Development Llc | Cell sorting apparatus and method |
| ES2690784T3 (es) | 2011-04-27 | 2018-11-22 | Becton Dickinson And Company | Dispositivos y métodos para separar fragmentos etiquetados magnéticamente en una muestra |
| JP5812469B2 (ja) * | 2011-05-18 | 2015-11-11 | 国立大学法人広島大学 | 細胞分離チップ |
| RU2631807C2 (ru) * | 2011-06-02 | 2017-09-26 | Президент Энд Феллоуз Ов Харвард Колледж | Способы и применение систем культуры ткани ex vivo |
| DE102011080012B4 (de) | 2011-07-28 | 2015-09-10 | Siemens Aktiengesellschaft | Strömungsmechanische Zellführung für Durchflusszytometrie |
| US9731062B2 (en) * | 2011-08-29 | 2017-08-15 | The Charles Stark Draper Laboratory, Inc. | System and method for blood separation by microfluidic acoustic focusing |
| USD702364S1 (en) * | 2011-12-20 | 2014-04-08 | SYFR, Inc. | Auto-staining cartridge |
| JP2015503736A (ja) | 2011-12-29 | 2015-02-02 | ダンマークス テクニスク ユニバーシテット | 電磁放射を用いて微小物体を分類するためのシステム |
| KR101211862B1 (ko) * | 2012-04-30 | 2012-12-12 | 한국기계연구원 | 자기장을 이용하는 자가 세포 추출장치 및 이를 이용하는 방법 |
| WO2014003689A1 (en) * | 2012-06-28 | 2014-01-03 | Nanyang Technological University | Detection device and method for detection of particles |
| US10130951B2 (en) | 2012-09-18 | 2018-11-20 | Cynvenio Biosystems, Inc. | Open-ended conical tube for recovering cells from a microfludic chip |
| CN107803227B (zh) * | 2012-09-18 | 2019-11-19 | 珠海圣美生物诊断技术有限公司 | 流体储存器 |
| EP2908140B1 (en) * | 2012-10-15 | 2019-08-14 | National University Corporation Nagoya University | Microchannel chip for microparticle separation, microparticle separation method and system for microparticle separation using chip |
| US8956536B2 (en) | 2012-10-26 | 2015-02-17 | Becton, Dickinson And Company | Devices and methods for manipulating components in a fluid sample |
| US20140242603A1 (en) * | 2013-02-26 | 2014-08-28 | Glenn Yaguang Deng | Methods and apparatus for target cell magnetic enrichment, isolation and biological analysis |
| US10166323B2 (en) | 2013-03-08 | 2019-01-01 | The Charles Stark Draper Laboratories, Inc. | Blood separation by microfluidic acoustic focusing |
| USD758372S1 (en) * | 2013-03-13 | 2016-06-07 | Nagrastar Llc | Smart card interface |
| US9888283B2 (en) | 2013-03-13 | 2018-02-06 | Nagrastar Llc | Systems and methods for performing transport I/O |
| CN105283753B (zh) * | 2013-03-14 | 2020-07-10 | 塞通诺米/St有限责任公司 | 流体动力聚焦设备和方法 |
| US12016682B2 (en) | 2013-03-14 | 2024-06-25 | The Regents Of The University Of California | In-vivo monitoring of molecular targets |
| EP2971279B1 (en) | 2013-03-15 | 2019-11-13 | The Trustees of Princeton University | Methods and devices for high throughput purification |
| CN109100288A (zh) | 2013-03-15 | 2018-12-28 | 艾瑞思国际股份有限公司 | 用于血液样品中的粒子分析的鞘流体系统和方法 |
| US20150064153A1 (en) | 2013-03-15 | 2015-03-05 | The Trustees Of Princeton University | High efficiency microfluidic purification of stem cells to improve transplants |
| BR112015021902B1 (pt) | 2013-03-15 | 2021-06-15 | Iris International, Inc | Líquido para alinhamento de partícula e organela intracelular |
| US11493428B2 (en) | 2013-03-15 | 2022-11-08 | Gpb Scientific, Inc. | On-chip microfluidic processing of particles |
| JP6493204B2 (ja) * | 2013-05-08 | 2019-04-03 | ソニー株式会社 | 流路デバイス、分析装置及び流体装置 |
| US8961904B2 (en) | 2013-07-16 | 2015-02-24 | Premium Genetics (Uk) Ltd. | Microfluidic chip |
| JP6205055B2 (ja) * | 2013-07-16 | 2017-09-27 | プレミアム ジェネティクス (ユーケー) リミテッド | マイクロ流体チップ |
| WO2015035467A1 (en) * | 2013-09-11 | 2015-03-19 | Active Magnetics Research Pty Ltd | Apparatus and method for entrapping magnetic material |
| EP3560591B1 (en) * | 2013-10-18 | 2021-02-17 | The General Hospital Corporation | Microfluidic sorting using high gradient magnetic fields |
| GB2523293A (en) * | 2013-10-24 | 2015-08-26 | Vws Uk Ltd | Method and Apparatus for measuring fluorescence in organisms |
| CN115266543A (zh) * | 2013-10-30 | 2022-11-01 | Abs全球公司 | 识别对象的装置及相关方法 |
| US11796449B2 (en) | 2013-10-30 | 2023-10-24 | Abs Global, Inc. | Microfluidic system and method with focused energy apparatus |
| CN105980581B (zh) | 2013-12-12 | 2021-03-26 | 阿尔查技术有限公司 | 电容传感器及使用方法 |
| WO2015089621A1 (en) * | 2013-12-18 | 2015-06-25 | Handyem Inc. | Chip assembly, flow cell and flow cytometer for characterizing particles |
| EP4086618A1 (en) | 2014-01-15 | 2022-11-09 | Caliper Life Sciences, Inc. | System of microfluidic immunoassay using magnetic beads |
| AU2015222978B2 (en) | 2014-02-26 | 2021-05-13 | Beth Israel Deaconess Medical Center | System and method for cell levitation and monitoring |
| WO2015157448A1 (en) * | 2014-04-08 | 2015-10-15 | Vanderbilt University | Low resource method and device for detecting analytes |
| JP6308525B2 (ja) | 2014-04-11 | 2018-04-11 | 国立大学法人名古屋大学 | 微粒子分離用チップ、該微粒子分離用チップを用いた微粒子分離用システム及び微粒子分離方法 |
| DE102014106603A1 (de) * | 2014-05-12 | 2015-11-12 | Verein zur Förderung von Innovationen durch Forschung, Entwicklung und Technologietransfer e.V. (Verein INNOVENT e.V.) | Verfahren und Vorrichtung zur Abreicherung von zirkulierenden Tumorzellen aus einer Zellsuspension |
| CN107075556B (zh) * | 2014-05-15 | 2022-09-20 | 流动生物科学公司 | 使用基于磁性和尺寸的分离进行细胞分离的方法和系统 |
| CN105530640B (zh) * | 2014-09-30 | 2019-02-22 | 国际商业机器公司 | 用于通信控制的方法和装置 |
| US10180388B2 (en) | 2015-02-19 | 2019-01-15 | 1087 Systems, Inc. | Scanning infrared measurement system |
| KR20160120416A (ko) * | 2015-04-08 | 2016-10-18 | 인제대학교 산학협력단 | 분리 가능한 복수의 패널을 포함하는 미세 입자 분리 장치 어셈블리 |
| USD864968S1 (en) | 2015-04-30 | 2019-10-29 | Echostar Technologies L.L.C. | Smart card interface |
| CA2987069C (en) * | 2015-06-05 | 2024-06-18 | Novartis Ag | Flow-through paramagnetic particle-based cell separation and paramagnetic particle removal |
| WO2016210128A1 (en) | 2015-06-25 | 2016-12-29 | Cytonome/St, Llc | Microfluidic device and system using acoustic manipulation |
| US10976232B2 (en) | 2015-08-24 | 2021-04-13 | Gpb Scientific, Inc. | Methods and devices for multi-step cell purification and concentration |
| WO2017045703A1 (en) * | 2015-09-15 | 2017-03-23 | Siemens Healthcare Gmbh | A technique for focusing a sample in a flow |
| US10809180B2 (en) * | 2015-09-28 | 2020-10-20 | The Governing Council Of The University Of Toronto | Device for magnetic profiling of particles in a flow |
| CA3000010C (en) * | 2015-10-02 | 2025-05-06 | The Board Of Trustees Of The Leland Stanford Junior University | Sorting of biological and non-biological fragments using magnetic levitation |
| CN105597846B (zh) * | 2015-10-26 | 2017-11-28 | 深圳华迈兴微医疗科技有限公司 | 一种d‑二聚体定量检测的磁微粒化学发光微流控芯片 |
| CN105435868B (zh) * | 2015-10-26 | 2017-11-28 | 深圳华迈兴微医疗科技有限公司 | 定量检测全血中肌钙蛋白i的磁微粒化学发光微流控芯片 |
| US10717084B2 (en) * | 2015-11-09 | 2020-07-21 | Georgia Tech Research Corporation | Microfluidic devices for cellular sorting |
| US20170259262A1 (en) * | 2016-03-09 | 2017-09-14 | Intelligent Bio-Systems, Inc. | Laminar fluidic separation in flowcells for minimal reagent usage |
| WO2017161201A1 (en) | 2016-03-16 | 2017-09-21 | Cynvenio Biosystems Inc. | Cancer detection assay and related compositions, methods and systems |
| FR3050664B1 (fr) * | 2016-04-27 | 2018-05-25 | Microfactory | Systeme d'evaluation in vitro de l'efficacite d'un deodorant. |
| CN107442186B (zh) * | 2016-05-31 | 2020-06-09 | 深圳汇芯生物医疗科技有限公司 | 微流控芯片、基于微流控芯片的分析装置及分析方法 |
| CN107881104B (zh) * | 2016-09-30 | 2023-04-14 | 国立大学法人东京大学 | 粒子捕获用微装置以及使用它的粒子的捕获、浓缩或分离方法 |
| IT201600104601A1 (it) * | 2016-10-18 | 2018-04-18 | Menarini Silicon Biosystems Spa | Sistema microfluidico |
| AU2018291041B2 (en) | 2017-06-30 | 2021-08-05 | Inscripta, Inc. | Automated cell processing methods, modules, instruments, and systems |
| JP7089299B2 (ja) | 2017-07-21 | 2022-06-22 | シージーン アイエヌシー | 磁性モジュール及びカバーモジュールを用いた核酸抽出方法、磁性モジュール、カバーモジュール、部品、並びに自動化システム |
| US11648559B2 (en) * | 2017-08-04 | 2023-05-16 | University Of Georgia Research Foundation, Inc. | Devices and methods for separating circulating tumor cells from biological samples |
| US10738327B2 (en) | 2017-08-28 | 2020-08-11 | Inscripta, Inc. | Electroporation cuvettes for automation |
| CN111132765B (zh) * | 2017-09-19 | 2022-05-13 | 高保真生物技术有限公司 | 微流体系统中的颗粒分选 |
| US12115537B2 (en) | 2017-11-14 | 2024-10-15 | University Of Florida Research Foundation, Inc. | Magnetic separation system and devices |
| WO2019140104A1 (en) * | 2018-01-11 | 2019-07-18 | NanoCav, LLC | Microfluidic cellular device and methods of use thereof |
| US20190283022A1 (en) * | 2018-03-15 | 2019-09-19 | Behrad Vahidi | Highly parallel microfluidic blood separation device |
| EP3775159A4 (en) | 2018-03-29 | 2022-01-19 | Inscripta, Inc. | AUTOMATED REGULATION OF CELL GROWTH RATES FOR INDUCTION AND TRANSFORMATION |
| WO2019195934A1 (en) * | 2018-04-10 | 2019-10-17 | Xeinac Biotec Inc. | Microfluidic chip |
| US10376889B1 (en) | 2018-04-13 | 2019-08-13 | Inscripta, Inc. | Automated cell processing instruments comprising reagent cartridges |
| US10858761B2 (en) | 2018-04-24 | 2020-12-08 | Inscripta, Inc. | Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells |
| EP3796998A1 (en) | 2018-05-23 | 2021-03-31 | ABS Global, Inc. | Systems and methods for particle focusing in microchannels |
| AU2019292919A1 (en) | 2018-06-30 | 2021-03-11 | Inscripta, Inc. | Instruments, modules, and methods for improved detection of edited sequences in live cells |
| AU2019322870A1 (en) * | 2018-08-14 | 2021-03-04 | Inscripta, Inc. | Improved detection of nuclease edited sequences in automated modules and instruments via bulk cell culture |
| US10532324B1 (en) | 2018-08-14 | 2020-01-14 | Inscripta, Inc. | Instruments, modules, and methods for improved detection of edited sequences in live cells |
| US10752874B2 (en) | 2018-08-14 | 2020-08-25 | Inscripta, Inc. | Instruments, modules, and methods for improved detection of edited sequences in live cells |
| US11142740B2 (en) | 2018-08-14 | 2021-10-12 | Inscripta, Inc. | Detection of nuclease edited sequences in automated modules and instruments |
| EP3669982B1 (en) * | 2018-12-21 | 2022-02-02 | Helmholtz-Zentrum Dresden - Rossendorf e.V. | Microfluidic device, apparatus and method for enrichment and dilution of magnetic molecular entities |
| CN109746064B (zh) * | 2019-01-28 | 2021-10-15 | 武汉纺织大学 | 一种梯度磁场微流控芯片 |
| CN109735430B (zh) * | 2019-01-28 | 2021-12-14 | 武汉纺织大学 | 一种三维磁泳分离的微流控芯片 |
| US10551313B1 (en) * | 2019-04-15 | 2020-02-04 | The Florida International University Board Of Trustees | Surface plasmon resonance based mechanical sensing of beating heart cells |
| CN113784618B (zh) | 2019-04-18 | 2023-12-22 | 艾步思国际有限责任公司 | 用于连续添加冷冻保护剂的系统和工艺 |
| US10907125B2 (en) | 2019-06-20 | 2021-02-02 | Inscripta, Inc. | Flow through electroporation modules and instrumentation |
| CN114008070A (zh) | 2019-06-21 | 2022-02-01 | 因思科瑞普特公司 | 导致大肠杆菌赖氨酸产量增加的全基因组合理设计的突变 |
| US10927385B2 (en) | 2019-06-25 | 2021-02-23 | Inscripta, Inc. | Increased nucleic-acid guided cell editing in yeast |
| US12371652B2 (en) * | 2019-11-05 | 2025-07-29 | Sony Group Corporation | Priming method of microparticle sorting microchip, microparticle sorting method, microparticle sorting device, and program |
| US20220395834A1 (en) * | 2019-11-15 | 2022-12-15 | Redbud Labs, Inc. | Microfluidic device for and methods of using surface-attached posts and capture beads in a microfluidic chamber |
| CN111088146A (zh) * | 2020-01-09 | 2020-05-01 | 天津大学 | 一种从胸腔积液中筛分肿瘤细胞的微流控芯片 |
| US10689669B1 (en) | 2020-01-11 | 2020-06-23 | Inscripta, Inc. | Automated multi-module cell processing methods, instruments, and systems |
| US11628439B2 (en) | 2020-01-13 | 2023-04-18 | Abs Global, Inc. | Single-sheath microfluidic chip |
| CN115135370A (zh) | 2020-01-27 | 2022-09-30 | 因思科瑞普特公司 | 电穿孔模块和仪器 |
| JP2021153445A (ja) * | 2020-03-26 | 2021-10-07 | 株式会社エンプラス | 液体取扱装置および液体取扱方法 |
| US20210332388A1 (en) | 2020-04-24 | 2021-10-28 | Inscripta, Inc. | Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells |
| CN111621416A (zh) * | 2020-05-14 | 2020-09-04 | 南京大学 | 一种基于移动磁网的生物磁性分离方法 |
| US11787841B2 (en) | 2020-05-19 | 2023-10-17 | Inscripta, Inc. | Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli |
| CN111721705A (zh) * | 2020-06-12 | 2020-09-29 | 迪瑞医疗科技股份有限公司 | 一种妇科分泌物分析仪器用层流液及其制备方法 |
| WO2022011114A1 (en) * | 2020-07-08 | 2022-01-13 | Lumacyte, LLC | Sampling device and systems |
| AU2021365488A1 (en) | 2020-10-21 | 2023-06-01 | Abs Global, Inc. | Methods and systems for processing genetic samples to determine identity or detect contamination |
| CN112372584B (zh) * | 2020-10-23 | 2021-12-03 | 浦江县颐硕科技开发有限公司 | 一种双头非牛顿式敲击锤及其调节方法 |
| CN116472118A (zh) * | 2020-11-19 | 2023-07-21 | Dh科技发展私人贸易有限公司 | 用于处理流体样品的系统和方法 |
| WO2022108840A1 (en) | 2020-11-23 | 2022-05-27 | Abs Global, Inc. | Modular flow cytometry systems and methods of processing samples |
| EP4194542A1 (en) * | 2021-12-07 | 2023-06-14 | Fluigent | Apparatus for feeding a liquid medium to a fluidic system |
| WO2023141199A2 (en) * | 2022-01-21 | 2023-07-27 | Trustees Of Dartmouth College | Microtransfer patterning of magnetic materials for microfluidic applications |
| WO2024137514A1 (en) | 2022-12-22 | 2024-06-27 | Synthego Corporation | Systems and method for automated oligonucleotide synthesis |
| CN116338156A (zh) * | 2023-02-24 | 2023-06-27 | 桂林优利特医疗电子有限公司 | 一种应用多方法学进行微粒子分析的液路系统 |
| CN116410848B (zh) * | 2023-06-09 | 2023-08-11 | 四川大学 | 一种无标记的高侵袭性循环肿瘤细胞捕获、培养芯片 |
| CN119319034A (zh) * | 2023-07-17 | 2025-01-17 | 深圳赛桥生物创新技术有限公司 | 磁分选容器、装置、方法和介质 |
| CN116679043B (zh) * | 2023-08-03 | 2023-11-03 | 天津大学 | 适用于磁泳分析平台的机器人及制备方法、磁泳分析平台 |
| JP2025048837A (ja) * | 2023-09-20 | 2025-04-03 | ソフトバンクグループ株式会社 | システム |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894146A (en) * | 1986-01-27 | 1990-01-16 | University Of Utah | Thin channel split flow process and apparatus for particle fractionation |
| US5108933A (en) | 1988-09-16 | 1992-04-28 | Immunicon Corporation | Manipulation of colloids for facilitating magnetic separations |
| US4893496A (en) * | 1988-10-14 | 1990-01-16 | Panametrics, Inc. | Torsional wave fluid sensor and system |
| US5770029A (en) * | 1996-07-30 | 1998-06-23 | Soane Biosciences | Integrated electrophoretic microdevices |
| WO1994011078A1 (en) | 1992-11-16 | 1994-05-26 | Immunivest Corporation | Magnetic immobilization and manipulation of biological entities |
| US5200084A (en) | 1990-09-26 | 1993-04-06 | Immunicon Corporation | Apparatus and methods for magnetic separation |
| US5622831A (en) * | 1990-09-26 | 1997-04-22 | Immunivest Corporation | Methods and devices for manipulation of magnetically collected material |
| US5795470A (en) * | 1991-03-25 | 1998-08-18 | Immunivest Corporation | Magnetic separation apparatus |
| US5466574A (en) * | 1991-03-25 | 1995-11-14 | Immunivest Corporation | Apparatus and methods for magnetic separation featuring external magnetic means |
| US5646001A (en) | 1991-03-25 | 1997-07-08 | Immunivest Corporation | Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof |
| US5186827A (en) | 1991-03-25 | 1993-02-16 | Immunicon Corporation | Apparatus for magnetic separation featuring external magnetic means |
| US6001229A (en) * | 1994-08-01 | 1999-12-14 | Lockheed Martin Energy Systems, Inc. | Apparatus and method for performing microfluidic manipulations for chemical analysis |
| DE19520298A1 (de) * | 1995-06-02 | 1996-12-05 | Bayer Ag | Sortiervorrichtung für biologische Zellen oder Viren |
| US5660990A (en) | 1995-08-18 | 1997-08-26 | Immunivest Corporation | Surface immobilization of magnetically collected materials |
| US20030215798A1 (en) * | 1997-06-16 | 2003-11-20 | Diversa Corporation | High throughput fluorescence-based screening for novel enzymes |
| US6660159B1 (en) * | 1996-06-07 | 2003-12-09 | Immunivest Corporation | Magnetic separation apparatus and methods |
| US6890426B2 (en) | 1996-06-07 | 2005-05-10 | Immunivest Corporation | Magnetic separation apparatus and methods |
| JP3996644B2 (ja) * | 1996-06-07 | 2007-10-24 | イムニベスト・コーポレイション | 外部及び内部勾配を有する磁気分離 |
| US7666308B2 (en) * | 1996-06-07 | 2010-02-23 | Veridex, Llc. | Magnetic separation apparatus and methods |
| EP0925494B1 (en) * | 1996-09-04 | 2001-12-19 | Scandinavian Micro Biodevices A/S | A micro flow system for particle separation and analysis |
| US6686208B2 (en) * | 1997-03-18 | 2004-02-03 | Institut Fur Chemo- Und Biosensorik Munster E.V. | Device and method for carrying out fluoresence immunotests |
| US6623983B1 (en) * | 1997-03-25 | 2003-09-23 | Immunivest Corporation | Apparatus and methods for capture and analysis of particulate entities |
| JP2002507750A (ja) | 1998-03-25 | 2002-03-12 | トリオン ダイアグノスティクス アクティー ゼルスカブ | 場による粒子操作のためのマイクロシステムおよび方法 |
| DE19815882A1 (de) * | 1998-04-08 | 1999-10-14 | Fuhr Guenther | Verfahren und Vorrichtung zur Manipulierung von Mikropartikeln in Fluidströmungen |
| US6250475B1 (en) * | 1998-05-01 | 2001-06-26 | Magnetic Products, Inc. | Permanent magnet separator having moveable stripper plate |
| ES2313800T3 (es) | 1998-11-30 | 2009-03-01 | Veridex, Llc | Aparato y procedimiento de separacion magnetica. |
| US6858439B1 (en) * | 1999-03-15 | 2005-02-22 | Aviva Biosciences | Compositions and methods for separation of moieties on chips |
| JP2001137613A (ja) * | 1999-11-11 | 2001-05-22 | Kawamura Inst Of Chem Res | 抽出機構を有する微小ケミカルデバイス |
| CA2397341A1 (en) | 2000-01-13 | 2001-07-19 | Dhanesh Gohel | Ferrofluid based arrays |
| US20040009614A1 (en) * | 2000-05-12 | 2004-01-15 | Ahn Chong H | Magnetic bead-based arrays |
| AU2001274869A1 (en) * | 2000-05-20 | 2001-12-03 | The Regents Of The University Of Michigan | Method of producing a dna library using positional amplification |
| EP1350095B1 (en) * | 2000-06-14 | 2015-12-09 | The Board Of Regents, The University Of Texas System | Method and apparatus for combined magnetophoretic and dielectrophoretic manipulation of analyte mixtures |
| AU2001282785A1 (en) * | 2000-08-23 | 2002-03-04 | Imego Ab | A sample collecting arrangement and a method |
| US6833542B2 (en) * | 2000-11-13 | 2004-12-21 | Genoptix, Inc. | Method for sorting particles |
| US6736978B1 (en) * | 2000-12-13 | 2004-05-18 | Iowa State University Research Foundation, Inc. | Method and apparatus for magnetoresistive monitoring of analytes in flow streams |
| EP1356420B1 (en) | 2001-01-05 | 2006-10-11 | Immunivest Corporation | Devices and methods to image objects |
| KR100916074B1 (ko) * | 2001-03-09 | 2009-09-08 | 바이오마이크로 시스템즈, 인크. | 어레이에 대한 마이크로유체 인터페이스 방법 및인터페이스용 시스템 |
| US20020166760A1 (en) * | 2001-05-11 | 2002-11-14 | Prentiss Mara G. | Micromagentic systems and methods for microfluidics |
| US7075162B2 (en) * | 2001-08-30 | 2006-07-11 | Fluidigm Corporation | Electrostatic/electrostrictive actuation of elastomer structures using compliant electrodes |
| KR100442836B1 (ko) * | 2001-11-10 | 2004-08-02 | 삼성전자주식회사 | 생화학 유체를 온도가 다른 폐쇄된 챔버 구간을 따라 회전이동시키는 폐쇄 유체 회로 시스템 |
| US20050164181A1 (en) * | 2001-11-27 | 2005-07-28 | Thomas Bricson | Nanostructure, in particular for analysing individual molecules |
| US20030186465A1 (en) | 2001-11-27 | 2003-10-02 | Kraus Robert H. | Apparatus used in identification, sorting and collection methods using magnetic microspheres and magnetic microsphere kits |
| US7232691B2 (en) * | 2001-11-27 | 2007-06-19 | Los Alamos National Security, Llc | Bioassay and biomolecular identification, sorting, and collection methods using magnetic microspheres |
| GB2383127B (en) * | 2001-12-12 | 2004-10-20 | Proimmune Ltd | Device and method for investigating analytes in liquid suspension or solution |
| AU2003216175A1 (en) * | 2002-02-04 | 2003-09-02 | Colorado School Of Mines | Laminar flow-based separations of colloidal and cellular particles |
| US7764821B2 (en) * | 2002-02-14 | 2010-07-27 | Veridex, Llc | Methods and algorithms for cell enumeration in a low-cost cytometer |
| US20030175980A1 (en) * | 2002-03-14 | 2003-09-18 | Hayenga Jon W. | Ribbon flow cytometry and cell sorting |
| US7312085B2 (en) * | 2002-04-01 | 2007-12-25 | Fluidigm Corporation | Microfluidic particle-analysis systems |
| US20040018611A1 (en) * | 2002-07-23 | 2004-01-29 | Ward Michael Dennis | Microfluidic devices for high gradient magnetic separation |
| US7118676B2 (en) | 2003-09-04 | 2006-10-10 | Arryx, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
| US20040043506A1 (en) * | 2002-08-30 | 2004-03-04 | Horst Haussecker | Cascaded hydrodynamic focusing in microfluidic channels |
| US7371051B2 (en) * | 2002-09-09 | 2008-05-13 | The Trustees Of The University Of Pennsylvania | Controlled magnetohydrodynamic fluidic networks and stirrers |
| US6919637B2 (en) * | 2002-09-30 | 2005-07-19 | Intel Corporation | Interconnect structure for an integrated circuit and method of fabrication |
| US20040121413A1 (en) * | 2002-12-20 | 2004-06-24 | Aebersold Rudolf H. | Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions |
| US7282180B2 (en) * | 2003-07-02 | 2007-10-16 | Immunivest Corporation | Devices and methods to image objects |
| WO2005059506A2 (en) * | 2003-07-08 | 2005-06-30 | Johns Hopkins University | Method and magnetic microarray system for trapping and manipulating cells |
| JP2005030906A (ja) * | 2003-07-11 | 2005-02-03 | Mitsubishi Chemicals Corp | 分析用チップ及び分析方法 |
| SG149889A1 (en) * | 2003-10-30 | 2009-02-27 | Cytonome Inc | Multilayer hydrodynamic sheath flow structure |
| JP4617779B2 (ja) * | 2003-11-25 | 2011-01-26 | 豊田合成株式会社 | キャップ装置 |
| WO2005065267A2 (en) * | 2003-12-24 | 2005-07-21 | Massachusetts Institute Of Technology | Magnetophoretic cell clarification |
| JP2007533305A (ja) * | 2004-03-03 | 2007-11-22 | ザ ジェネラル ホスピタル コーポレーション | 微小流動環境において細胞および生体分子を単離するための磁気装置 |
| US7442339B2 (en) * | 2004-03-31 | 2008-10-28 | Intel Corporation | Microfluidic apparatus, Raman spectroscopy systems, and methods for performing molecular reactions |
| US20060020371A1 (en) * | 2004-04-13 | 2006-01-26 | President And Fellows Of Harvard College | Methods and apparatus for manipulation and/or detection of biological samples and other objects |
| US20050274650A1 (en) * | 2004-06-09 | 2005-12-15 | Georgia Tech Research Corporation | Blood separation systems in micro device format and fabrication methods |
| DE102004040785B4 (de) | 2004-08-23 | 2006-09-21 | Kist-Europe Forschungsgesellschaft Mbh | Mikrofluidisches System zur Isolierung biologischer Partikel unter Verwendung der immunomagnetischen Separation |
| US7824620B2 (en) | 2004-09-21 | 2010-11-02 | The Trustees Of The University Of Pennsylvania | Nano- and micro-scale structures: methods, devices and applications thereof |
| US20060177815A1 (en) * | 2004-11-29 | 2006-08-10 | The Regents Of The University Of California | Dielectrophoretic particle sorter |
| US20070196820A1 (en) * | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
| US7749445B2 (en) * | 2005-05-02 | 2010-07-06 | Bioscale, Inc. | Method and apparatus for analyzing bioprocess fluids |
| US20090201504A1 (en) * | 2005-08-09 | 2009-08-13 | Maxwell Sensors, Inc. | Hydrodynamic focusing for analyzing rectangular microbeads |
| WO2007044642A2 (en) * | 2005-10-06 | 2007-04-19 | President And Fellows Of Harvard College And Children's Medical Center Corporation | Device and method for combined microfluidic-micromagnetic separation of material in continuous flow |
| GB0523631D0 (en) * | 2005-11-21 | 2005-12-28 | Univ Cambridge Tech | Magnetic tagging techniques |
| US7807454B2 (en) * | 2006-10-18 | 2010-10-05 | The Regents Of The University Of California | Microfluidic magnetophoretic device and methods for using the same |
| US8586385B2 (en) * | 2006-12-28 | 2013-11-19 | Intel Corporation | Method and device for biomolecule preparation and detection using magnetic array |
| US7412131B2 (en) * | 2007-01-02 | 2008-08-12 | General Electric Company | Multilayer optic device and system and method for making same |
| WO2009008925A2 (en) * | 2007-04-05 | 2009-01-15 | The Regents Of The University Of California | A particle-based microfluidic device for providing high magnetic field gradients |
| WO2008131048A2 (en) * | 2007-04-16 | 2008-10-30 | Cellpoint Diagnotics, Inc. | Devices and methods for diagnosing, prognosing, or theranosing a condition by enriching rare cells |
| ATE554859T1 (de) * | 2007-05-24 | 2012-05-15 | Univ California | Integrierte fluidische vorrichtungen mit magnetischer sortierung |
| CN101842161A (zh) * | 2007-08-23 | 2010-09-22 | 辛温尼奥生物系统公司 | 用于目标物质的俘获磁性拣选系统 |
| US7736891B2 (en) * | 2007-09-11 | 2010-06-15 | University Of Washington | Microfluidic assay system with dispersion monitoring |
| US9480935B2 (en) * | 2008-02-01 | 2016-11-01 | Lawrence Livermore National Security, Llc | Systems and methods for separating particles and/or substances from a sample fluid |
| WO2009117611A2 (en) * | 2008-03-19 | 2009-09-24 | Cynvenio Biosystems, Llc | Trapping magnetic cell sorting system |
| EP2271919A1 (en) | 2008-04-16 | 2011-01-12 | Cynvenio Biosystems, Inc. | Magnetic separation system with pre and post processing modules |
| US8154273B2 (en) * | 2008-10-10 | 2012-04-10 | Beckman Coulter, Inc. | Detecting and handling coincidence in particle analysis |
| WO2010053796A2 (en) * | 2008-10-28 | 2010-05-14 | The Regents Of The University Of Colorado, A Body Corporate | Microfluidic cell sorter utilizing broadband coherent anti-stokes raman scattering |
-
2010
- 2010-06-10 PT PT107868739T patent/PT2440941T/pt unknown
- 2010-06-10 PL PL10786873T patent/PL2440941T3/pl unknown
- 2010-06-10 DK DK10786873.9T patent/DK2440941T3/en active
- 2010-06-10 CN CN201080035957.XA patent/CN102713640B/zh active Active
- 2010-06-10 EP EP10786873.9A patent/EP2440941B1/en not_active Not-in-force
- 2010-06-10 US US12/813,285 patent/US8263387B2/en active Active
- 2010-06-10 JP JP2012515162A patent/JP5337912B2/ja not_active Expired - Fee Related
- 2010-06-10 SM SM20170421T patent/SMT201700421T1/it unknown
- 2010-06-10 WO PCT/US2010/038229 patent/WO2010144745A2/en not_active Ceased
-
2012
- 2012-08-03 US US13/566,930 patent/US20120301883A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US8263387B2 (en) | 2012-09-11 |
| EP2440941A4 (en) | 2013-01-02 |
| PL2440941T3 (pl) | 2017-10-31 |
| PT2440941T (pt) | 2017-07-31 |
| JP2012530246A (ja) | 2012-11-29 |
| EP2440941B1 (en) | 2017-05-31 |
| DK2440941T3 (en) | 2017-08-28 |
| WO2010144745A3 (en) | 2011-04-14 |
| US20120301883A1 (en) | 2012-11-29 |
| CN102713640B (zh) | 2015-09-16 |
| EP2440941A2 (en) | 2012-04-18 |
| US20110003303A1 (en) | 2011-01-06 |
| SMT201700421T1 (it) | 2017-11-15 |
| WO2010144745A2 (en) | 2010-12-16 |
| CN102713640A (zh) | 2012-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5337912B2 (ja) | シース流装置及び方法 | |
| AU2022201238B2 (en) | Flow cells utilizing surface-attached structures, and related systems and methods | |
| Hosic et al. | Microfluidic sample preparation for single cell analysis | |
| US20250333684A1 (en) | Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof | |
| US20090053799A1 (en) | Trapping magnetic sorting system for target species | |
| US20110127222A1 (en) | Trapping magnetic cell sorting system | |
| Khan et al. | Microfluidic devices in the fast‐growing domain of single‐cell analysis | |
| US20210316303A1 (en) | Flow cells utilizing surface-attached structures, and related systems and methods | |
| Lu et al. | Automatic Microfluidic Cell Wash Platform for Purifying Cells in Suspension: Puriogen | |
| US20210220827A1 (en) | Systems and methods for nucleic acid purification using flow cells with actuated surface-attached structures | |
| US20240316549A1 (en) | Systems and methods for nucleic acid purification using flow cells with actuated surface-attached structures | |
| CA2998812C (en) | Flow cells utilizing surface-attached structures, and related systems and methods | |
| Bhatt et al. | Microfluidics assisted cell engineering and manipulation | |
| Pahattuge | Integrated Modular Microfluidic Systems for the Affinity Selection and Comprehensive Analysis of Rare Liquid Biopsy Biomarkers | |
| Nayyab et al. | Microfluidics-An Emerging Technology; Its Types and Applications | |
| Cao | Microfluidic Engineering for Ultrasensitive Molecular Analysis of cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130606 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130606 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20130606 |
|
| TRDD | Decision of grant or rejection written | ||
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20130709 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130716 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130805 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5337912 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |